Today’s AI Top Pick: ZTS

8/5/2026 · Reliable Bullish screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · ZTS65%361 resolved forecasts · 45d window · verify →

View the live ZTS price forecast →

Today's pick · Reliable BullishZTSBUY NOW8.8 / 108/5/2026

Zoetis (ZTS) is the cleanest set-up in this pool: it combines the highest-quality fundamentals with a rare 4-timeframe forecast agreement while sitting near the bottom of its longer-term range. Bullish_prob = 1, near_term_bullish = 1, and every single timeframe forecast is positive to strongly positive — 1h fc_short +25.5%, 4h +28.7/+45.2/+56.9%, 1d +18.8/+48.3/+59.7%, and 1wk +28.8/+90.2/+115.0%. That is the 'gold' four-TF alignment the brief calls out, and the weekly magnitudes are the highest in the pool for a mega-cap. Crucially, ZTS is NOT extended. Weekly position_in_21bar_range = 4.55% with a -37.3% weekly drawdown, and 1h position is only 19.55% — you're buying near the low of a multi-quarter reset, not chasing a breakout. Contrast this with the names sitting at 100% of range (PDD, FUTU, ACM, BR, TRMB, ADSK, QTWO) that the framework explicitly penalizes. Fundamentals are best-in-pool for a large cap: PE 12.6, fwdPe 10.34, ROE 67.01%, profitMargin 27.79%, operMargin 37.57%, epsNextY +7.07%, targetUpsidePct 34.7%, fundamental_score 7.75. Recom 2.0 with debtEq 2.86 is the only caution (typical for ZTS pharma-like leverage). News is a mild positive — a Burry position and an upcoming OA-drug pipeline push were both flagged 8/4, alongside a Q2 earnings preview. Yes, earnings are the near-term event risk, but the deep drawdown, low range position, and consensus forecasts skewed to the upside make asymmetric risk favorable TODAY rather than waiting to chase a post-print gap. PODD is the strong runner-up but has weaker fundamentals (fwdPe 20.7, margin 10.4) and only near_term 0.8; ZTS wins on quality + confirmation.

ZTS forecast chart
Entry zone
$74.80 – $76.20 (scale in around current $75.86; add on any dip to $74)
Stop loss
$71.50 (below the recent weekly low; ~-5.8% risk, protects against post-earnings gap)
First target
$85 (~+12%, roughly the 4h fc_mid +45% path over 4-6 weeks)
Longer target
$105–$115 (aligned with 1wk fc_long +115% and 34.7% analyst upside; 6-12 month swing)
Risks
  • Q2 2026 earnings are imminent (headlined 8/4) — a soft print or guide could invalidate the setup and push price toward the $71.5 stop
  • debtEq 2.86 is elevated; a rate re-acceleration would compress the multiple even with strong ROE 67
  • 1h fc_mid/long are actually -11.5% — very short-term chop is possible before the daily/weekly thesis plays out
  • Weekly drawdown -37.3% and pos 4.55% mean the stock is in a broken tape; a failed bounce here could see it retest lows
  • Animal-health pricing/tariff headline risk on companion-animal franchise (Simparica, Librela) which drove the -49.9% YoY decline
Honorable mentions
PODDBullish_prob 1, near_term 0.8, at the bottom of both 4h (20.87%) and 1d (0%) ranges with 1d fc_long +66% and 1wk +54%; salesYoY 31.9%. Slightly weaker fundamentals than ZTS (fwdPe 20.7, margin 10.4) but same 'low-in-range + strong forecast' pattern. Earnings pending is the caveat.
TMEBullish_prob 1, near_term 0.8, forecasts of +37/+49/+61% (4h) and +72% (1d long); PE 11.75, fwdPe 9.75, profitMargin 26.5%. Not stretched (weekly pos 69%, dd -5%) and a SeekingAlpha 'Reiterate Buy' catalyst. Earnings coming next week is a swing catalyst.
Full ranking (30)
#SymbolVerdictScoreRead
1ZTSBUY NOW8.8Four-timeframe bullish alignment, near range lows, best-in-pool ROE 67 and PE 12.6 with 1wk fc_long +115%.
2PODDBUY NOW8.2Low in 1d/4h range with 1d fc_long +66%, bullish_prob 1, near_term 0.8; quality growth name post -42% reset.
3TMEBUY NOW7.7PE 11.75 + 26% margins with +61% 4h and +72% 1d long forecasts, not yet at range highs.
4MNSOBUY NOW7.4PEG 0.16, salesYoY 30.5%, mid-range position with 4h/1d forecasts +54%/+52% and near_term 0.8.
5TIGRBUY NOW7.2Near_term 1 with 4h +68% and 1d +79% mid forecasts; fwdPe 6.11 and salesYoY 48% support the tape.
6STNBUY NOW7.0All four TFs positive, near_term 1, recom 1.31 with steady 1d fc_long +29%.
7DOXBUY NOW6.9Bullish_prob 1, near_term 0.8, fwdPe 7.04 with 1wk fc_long +46%; weekly drawdown -15% gives room.
8PEGABUY PULLBACK6.6Weekly dd -27% with 1d fc_mid +52%; ROE 54.7, PE 17.9, but short_float 17.8% adds volatility.
9KMPRBUY PULLBACK6.51wk fc_long +83.9% and epsNextY +122%; recom 3 and weak margins argue for patience/pullback.
10ACMBUY PULLBACK6.3Fundamentals solid (ROE 27.7, recom 1.38) but at 100% of 4h/1d range — wait for retrace.
11FIGRBUY PULLBACK6.2Bullish_prob null but 4h forecasts +40/+43/+49% with -19% drawdown; needs signal confirmation.
12SPROBUY PULLBACK6.0Huge forecast (+97% 4h) and Innovent $1.1B license catalyst, but $71M micro-cap and negative weekly forecasts.
13WAYBUY PULLBACK5.8Recent Buy upgrade, but near_term only 0.2 and at 99% of 4h range — wait for pullback.
14FINVBUY PULLBACK5.7Cheapest name here (PE 4.17, fwdPe 3.45) but at 100% of range and modest forecasts.
15MLCOBUY PULLBACK5.6PEG 0.35 and 1wk fc_long +40.9%, but weak profitability (margin 4.33) and near_term 0.4.
16FICOBUY PULLBACK5.4Deeply oversold (pos 2.6% on 1d, RSI 35), but recent headline 'trading lower' + rate-drag narrative caps conviction.
17ADSKWAIT5.2Strong fundamentals but at 100% of 4h range with only near_term 0.4 — chase risk.
18TRMBWAIT5.0At 100% of 4h/1d range with RSI 67.5 and negative 1wk fc_short -7.45%.
19PDDWAIT4.9Fundamentally excellent but at 100% of both intraday ranges — wait for a pullback.
20BRWAIT4.8RSI 70.26 and at 99% of 1d range; forecast magnitudes modest post earnings pop.
21ZWAIT4.6Big weekly forecasts but 500-person layoff announcement 8/4 is a mixed signal; PE 144.
22GDDYWAIT4.5PEG 0.51 but near_term only 0.2 and 1wk fc_mid negative; debtEq 573 is a red flag.
23NOWWAIT4.3Strong AI/security narrative but negative 1h/4h forecasts (-15/-17%) and at 100% of range.
24SEWAIT4.1Bullish_prob only 0.4, near_term 0.2, and 4h fc_short -14% — momentum stalling.
25INTUAVOID3.8Truist downgrade to Hold on softening growth (8/4) with negative 1h forecasts undercuts thesis.
26CCCAVOID3.7Bullish_prob 0.4, near_term 0, at 100% of 1d range with negative 4h forecasts.
27FUTUAVOID3.5DOJ probe and US class actions headline (7/3) — landmine outweighs +51% forecast.
28VERXAVOID3.3Near_term 0, PE 576, negative weekly forecasts, and multiple analyst PT cuts post-earnings.
29GDYNAVOID3.2Bullish_prob 0.4, near_term 0, at 100% of range with negative short forecasts across all TFs.
30QTWOAVOID2.8Bullish_prob 0.2, RSI 74.34, all TFs at 100% of range with negative forecasts — parabolic exhaustion.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord

⚠️ This AI-generated analysis is for informational purposes only and is not financial advice. Forecasts and scores are model outputs that can be wrong; markets involve substantial risk of loss. Do your own research.